Question 1

Does BNP Paribas Financial Markets own CAI stock?

Accepted Answer

Yes. As of its Q2 2026 13F, BNP Paribas Financial Markets holds 2,370,268 shares of CAI (Caris Life Sciences), worth $42.2M.

Question 2

How many shares of CAI does BNP Paribas Financial Markets own?

Accepted Answer

As of its Q2 2026 13F, BNP Paribas Financial Markets holds 2,370,268 shares of CAI (Caris Life Sciences).

Question 3

What is BNP Paribas Financial Markets' CAI position worth?

Accepted Answer

As of its Q2 2026 13F, BNP Paribas Financial Markets' CAI position is worth $42.2M.

Question 4

Is BNP Paribas Financial Markets buying or selling CAI?

Accepted Answer

In Q2 2026, BNP Paribas Financial Markets increased its CAI position by 755,982 shares (+46.8%).

Question 5

When did BNP Paribas Financial Markets first buy CAI?

Accepted Answer

BNP Paribas Financial Markets first reported CAI in its Q3 2025 13F and has listed it in 4 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	2.4M	+46.8%	$42.2M	0.0%	$17.82	40
2026-Q1	Increased	1.6M	+135.4%	$28.9M	0.0%	$19.38	46
2025-Q4	Increased	685,826	+571x	$18.5M	0.0%	$27.32	46
2025-Q3	New	1,200	-	$36,300	0.0%	$30.00	30

CAI4 quarters

CAI
4 quarters